Neurogen SRL
Neurogen reported revenue of 399,937 € for the 2025 financial year (annual accounts filed with the NBB on 02 Jun 2026).
The score of Neurogen shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +6 % Equity +12 % Total assets -9 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Neurogen's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 399,937 € | ||||
| Net result | 50,583 € | ||||
| Equity | 263,899 € | ||||
| Cash | 38,384 € | ||||
| EBITDA | 92,978 € | ||||
| Total assets | 305,427 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jun 2026
- Year ended 31 Dec 2024filed on 03 Jun 2025
- Year ended 31 Dec 2023filed on 29 May 2024
- Year ended 31 Dec 2022filed on 30 May 2023
- Year ended 31 Dec 2021filed on 17 Jun 2022
Neurogen's financial analysis
- Solvency86.4%sector median: 69.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Neurogen
Neurogen's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0474.427.988
- VAT number
- BE0474427988
- Peppol
- Registered · 0208:0474427988 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Mar 2001
- Registered office
- 1090 Jette
- Latest accounts
- 2025 · filed on 02 Jun 2026
- Activity
- General medical practice activities (NACE 86210)
Neurogen (SRL) has been based in Jette since 2001, active in: general medical practice activities. For 2025, it reports revenue of 399,937 €, a net profit of 50,583 € and equity of 263,899 €. Its solvency stands at 86.4%, above the median of its sector (69.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Neurogen
Companies in the same business, of comparable size and area, outside its group.
- Jenimed General medical practice activities Brussels · balance sheet 300,953 €
- Dr. Sjors Pietermans General medical practice activities Maasmechelen · balance sheet 305,112 €
- DMG health General medical practice activities Keerbergen · balance sheet 305,568 €
- Dr. Jens van Eccelpoel Huisarts General medical practice activities Aarschot · balance sheet 305,678 €
- De Brug General medical practice activities Brecht · balance sheet 305,894 €
- Ygeia Medical General medical practice activities Genk · balance sheet 304,906 €
- Dokter Hofman Evelien, huisarts General medical practice activities Merelbeke-Melle · balance sheet 306,092 €
- SRL Docteur Dupont Camille General medical practice activities Mons · balance sheet 306,553 €
Frequently asked questions about Neurogen
What is the revenue of Neurogen?
According to the 2025 annual accounts filed with the NBB, the revenue of Neurogen amounts to 399,937 €.
What is the VAT number of Neurogen?
In Belgium, the VAT number is the company number prefixed with BE: BE0474427988 for Neurogen, if the company is VAT-registered. Its company number (CBE) is 0474.427.988.
Where is the registered office of Neurogen?
According to the CBE register, the registered office of Neurogen is in 1090 Jette.
What is the equity of Neurogen?
At the close of the 2025 financial year, the equity of Neurogen amounts to 263,899 €, a solvency of 86.4% of total assets.
Who manages Neurogen?
The register lists 2 active mandates at Neurogen. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Neurogen
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →